AxoGen, Inc. (AXGN) Financials
AXGN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 186.5 million | 93.4 million |
2023-12-31 | 196.8 million | 101.2 million |
2023-09-30 | 194.6 million | 96.8 million |
2023-06-30 | 191.6 million | 94.5 million |
AXGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -13.6 million | ? |
2023-12-31 | -2.0 million | 1.3 million |
2023-09-30 | -2.3 million | 4.7 million |
2023-06-30 | -4.4 million | 5.4 million |
AXGN Net Income
No data available :(
AXGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 23.6 million | - | - |
2023-12-31 | 37.0 million | - | 22.7 million |
2023-09-30 | 32.6 million | - | 21.0 million |
2023-06-30 | 34.5 million | 46.2 million | 21.2 million |
AXGN Shares Outstanding
AXGN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 1.3 million | 7.4 million | 10.0 million | 19.8 million |
2023-12-31 | 1.8 million | 7.3 million | 7.5 million | 22.2 million |
2023-09-30 | 3.9 million | 7.0 million | 8.8 million | 21.4 million |
2023-06-30 | 4.7 million | 7.4 million | 9.6 million | 20.8 million |
AXGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 41.4 million | 8.8 million |
2023-12-31 | 42.9 million | 9.2 million |
2023-09-30 | 41.3 million | 8.0 million |
2023-06-30 | 38.2 million | 7.2 million |
AXGN
Price: $5.79
52 week price:
Earnings Per Share: -0.51 USD
P/E Ratio: -17.71
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 233500
Ebitda: -1.4 millionMarket Capitalization: 253.0 million
Average Dividend Frequency: 1